Form 4: Clorox Director Russell Weiner Reports Stock Acquisition

Director Russell Weiner acquired 498.0409 deferred stock units in The Clorox Company through dividend reinvestment and director fee compensation.

Summary

• Director Russell Weiner acquired 172.363 deferred stock units on February 13, 2026, via dividend reinvestment.
• Director Russell Weiner acquired 325.6779 deferred stock units on March 31, 2026, in lieu of quarterly director fees.
• The total beneficial ownership of deferred stock units following these transactions is 18,004.0034.
• These units are settled 1-for-1 in common stock upon the director's retirement or termination of service.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative filing reflecting standard director compensation and dividend reinvestment activity.

Positives

• Demonstrates alignment of director interests with shareholders through equity-based compensation.
• Reflects ongoing participation in the company's dividend reinvestment program.

Negatives

• None identified.

Risks

• Value of deferred stock units is tied directly to the future performance of Clorox common stock.

Future Outlook

The filing does not provide forward-looking guidance regarding company operations or financial performance.

Industry Context

StockSavvy.ai notes that routine director equity acquisitions via compensation plans are standard corporate governance practices and do not typically signal shifts in company strategy or market outlook.

Comparison to Industry Standards

• The use of deferred stock units for director compensation is a standard practice among S&P 500 consumer goods companies to ensure long-term alignment with shareholder interests.

Stakeholder Impact

• Minimal impact on shareholders as these are routine compensation-related transactions.

Next Steps

• No future actions or milestones were disclosed in this filing.

Key Dates

Keywords

Clorox, CLX, Insider Trading, Form 4, Director Compensation, Deferred Stock Units